ManRos Therapeutics is Drug Discovery in France that focus on renal diseases business. Founded in 2007. They cover business area such as developer, treatment, cystic fibrosis, neurodegenerative and renal disease, development, small-molecule drug, severe pathology, namely solid tumor, leukemia, polycystic kidney disease, medical practitioner, a reduce cost, industrial expert.
2007
( 17 years old in 2024 )
Renal Diseases
-
Hôtel de Recherche
Centre de Perharidy
29680 Roscoff
France
Private
developertreatmentcystic fibrosisneurodegenerative and renal diseasedevelopmentsmall-molecule drugsevere pathologynamely solid tumorleukemiapolycystic kidney diseasemedical practitionera reduce costindustrial expert
* We use standard office opening hours in near ManRos Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ManRos Therapeutics is Drug Discovery business from France that founded in 2007 (17 years old in 2024), ManRos Therapeutics business is focusing on Renal Diseases.
ManRos Therapeutics headquarter office and corporate office address is located in Hôtel de Recherche Centre de Perharidy 29680 Roscoff France.
ManRos Therapeutics was founded in France.
In 2024, ManRos Therapeutics is currently focus on renal diseases sector.
Above is snippet of Google Trends for "renal diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ManRos Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.